Note 7 - Stockholders' Equity (Deficit) (Details Textual) - USD ($)								1 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Aug. 01, 2019	Jun. 19, 2019	Nov. 01, 2018	Jul. 13, 2018	Jul. 12, 2018	Feb. 16, 2018	Feb. 14, 2018	Jan. 31, 2019	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Aug. 28, 2019	Aug. 22, 2018	Jan. 31, 2015
Preferred Stock, Shares Authorized									5,000,000			5,000,000		5,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001			$ 0.001			$ 0.001		$ 0.001
Preferred Stock, Shares Issued, Total									44,923			44,923		45,671
Debt Conversion, Original Debt, Amount													$ 38,000,000
Preferred Stock, Shares Outstanding, Ending Balance									44,923			44,923		45,671
Proceeds from Issuance or Sale of Equity, Net	$ 3,800,000		$ 10,200,000	$ 3		$ 15,500,000						$ 8,000,000
Preferred Stock Deemed Dividend Arising from Beneficial Conversion Feature													5,216,000
Common Stock, Shares Authorized									100,000,000			100,000,000		100,000,000
Common Stock, Par or Stated Value Per Share									$ 0.001			$ 0.001		$ 0.001
Common Stock, Shares, Outstanding, Ending Balance									10,342,179			10,342,179		3,492,200
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						1,797,900
Class of Warrant or Right, Outstanding									2,753,999			2,753,999		4,757,539
Proceeds from Warrant Exercises												$ 7,993,000	$ 581,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												4 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period												10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period													0
Share-based Payment Arrangement, Expense, Tax Benefit									$ 0	$ 0		$ 0	$ 0
Share Price									$ 0.83			$ 0.83
Common Stock, Shares, Issued, Total									10,342,179			10,342,179		3,492,200
Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total									$ 142,000			$ 142,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition												1 year
Restricted Stock Units (RSUs) [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total									$ 3,600,000			$ 3,600,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition												2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance									941,568			941,568		294,066
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Fair Value									$ 782,000			$ 782,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value												$ 110,000	$ 1,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value												$ 1.24	$ 15.80
Minimum [Member] | Common Stock Options [ member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent												100.00%
Minimum [Member] | Common Stock Options [ member] | Stockholder with More than 10% Voting Power [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent											110.00%
Minimum [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												3 years
Maximum [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												4 years
The 2015 Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																	3,300
Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Reserved for Issuance, Annual																	4,225
Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Reserved for Issuance, Percentage on Shares Outstanding																	5.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized		800,000												300,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant									68,954			68,954
Officer and Director Share Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized															40,000	20,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant									37,056			37,056
Stock Issued During Period, Shares, Employee Stock Purchase Plans												18,543
Common Stock Warrants, Issued with Series E Convertible Preferred Stock [Member]
Class of Warrant or Right, Securities Called as Percentage of Convertible Preferred Stock Shares									50.00%			50.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights											5,380
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 5,040
Common Stock Warrants, Issued with Series B Preferred Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						1,797,900			1,768,850			1,768,850
Common Stock Warrants, Issued with Series B Preferred Stock, Warrant One [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 4
Class of Warrant or Right, Number of Warrants Issued for Each Share of Preferred Stock						1
Class of Warrant or Right, Contingent Expiration Period Following Initial Exercise Date						7 years
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right						50
Common Stock Warrants, Issued with Series B Preferred Stock, Warrant Two [Member]
Class of Warrant or Right, Number of Warrants Issued for Each Share of Preferred Stock						1
Class of Warrant or Right, Contingent Expiration Period Following Initial Exercise Date						7 years
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right						50
Class of Warrant or Right, Expiration Period Following FDA Clearance						60 days
Common Stock Warrants [Member] | Placement Agency Sale - Prospectus Supplement of July 12, 2018 [Member]
Stock Issued During Period, Shares, New Issues					216,618
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				108,309	108,309
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 15.80	$ 15.80
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right					1
Common Stock Warrants [Member] | November Public Offering [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			2,875,000						876,840			876,840
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 4
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			1
Class of Warrant or Right, Outstanding														28,750,000
Class of Warrant or Right, Exercised												1,998,079
Proceeds from Warrant Exercises												$ 8,000,000
Preferred Stock Warrants [Member] | November Public Offering [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			250
Common Stock [Member]
Stock Issued During Period, Shares, New Issues			728,500							216,618		3,813,559
Stock Issued During Period, Shares, Employee Stock Purchase Plans									10,947	209		18,735	209
Common Stock [Member] | Placement Agency Sale - Prospectus Supplement of July 12, 2018 [Member]
Stock Issued During Period, Shares, New Issues				216,618									216,618
Common Stock [Member] | November Public Offering [Member]
Stock Issued During Period, Shares, New Issues			728,500
Conversion of Series B Preferred Stock into Common Stock [Member]
Conversion of Stock, Shares Converted												1,523
Conversion of Stock, Shares Issued												380,750
Conversion of Series C Preferred Stock into Common Stock [Member]
Conversion of Stock, Shares Converted												2,170
Conversion of Stock, Shares Issued												542,500
Series A Preferred Stock [Member]
Preferred Stock, Shares Outstanding, Ending Balance									44,745			44,745
Dividends, Preferred Stock, Total									$ 895,000	$ 836,000		$ 2,700,000	$ 2,100,000
Stock Issued During Period, Shares, New Issues						41,800
Series A Preferred Stock [Member] | CRG [Member]
Preferred Stock Dividends, Shares								2,945
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share						$ 0.001
Preferred Stock, Shares Outstanding, Ending Balance									178			178		1,701
Stock Issued During Period, Shares, New Issues						17,979
Preferred Stock Deemed Dividend Arising from Beneficial Conversion Feature						$ 5,200,000
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share			$ 0.001
Preferred Stock, Shares Outstanding, Ending Balance														2,170
Stock Issued During Period, Shares, New Issues			8,586
Proceeds from Issuance or Sale of Equity, Net			$ 10,200,000
Series C Preferred Stock [Member] | November Public Offering [Member]
Stock Issued During Period, Shares, New Issues			8,586
Proceeds from Issuance or Sale of Equity, Net			$ 10,200,000
Conversion of Principal Amount of Senior Secured Loan to Newly Authorized Series A Preferred Stock [Member] | Series A Preferred Stock [Member]
Convertible Preferred Stock, Shares of Common Stock Issuable on Conversion						2,090,000	2,090,000
Preferred Stock, Dividend Rate, Percentage							8.00%
CRG [Member] | Conversion of Principal Amount of Senior Secured Loan to Newly Authorized Series A Preferred Stock [Member]
Debt Conversion, Original Debt, Amount						$ 38,000,000	$ 38,000,000
Debt Conversion, Fees and Prepayment Premium Amount							3,800,000
Debt Conversion, Converted Instrument, Amount						$ 41,800,000	$ 41,800,000